Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Laboratory Hematology|May 21, 2009
Real-time PCR quantification of haematopoietic chimerism after transplantation: a comparison between TaqMan and hybridization probes technologiesJ Martínez-López, A Crooke, S Grande, et al.
Annals of Hematology|February 23, 2016
Current opinion and consensus statement regarding the diagnosis, prognosis, and treatment of patients with essential thrombocythemia: a survey of the Spanish Group of Ph-negative Myeloproliferative Neoplasms (GEMFIN) using the Delphi methodC Besses, J C Hernández-Boluda, M Pérez Encinas, et al.
Leukemia|January 28, 2005
Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphismsA Jiménez-Velasco, M Barrios, J Román-Gómez, et al.
Oncogene|November 30, 2005
ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemiaX Agirre, J Román-Gómez, A Jiménez-Velasco, et al.
Annals of Hematology|April 25, 2012
Comparative study of BCR-ABL1 quantification: Xpert assay, a feasible solution to standardization concernsC E López-Jorge, M T Gómez-Casares, A Jiménez-Velasco, et al.
Bone Marrow Transplantation|September 15, 2015
UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantationN Santos, R Rodríguez-Romanos, J B Nieto, et al.
Bone Marrow Transplantation|April 2, 2013
A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCTB Martín-Antonio, M Suarez-Lledo, M Arroyes, et al.
Annals of Hematology|August 23, 2022
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemiaA Luna, L Pérez-Lamas, C Boque, et al.
Pageof 1